Tax

Unrecognized Tax Benefits Reevaluation (Statute Lapse)

Vertex Pharmaceuticals Unrecognized Tax Benefits Reevaluation (Statute Lapse) remained flat by 0.0% to $2.68M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 35.5%, from $4.15M to $2.68M. Over 2 years (FY 2023 to FY 2025), Unrecognized Tax Benefits Reevaluation (Statute Lapse) shows an upward trend with a 14.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement
SectionTax
CategoryRisk
SignalHigher is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ4 2025

How to read this metric

A higher value indicates that older, unresolved tax positions are expiring, potentially reducing future tax risk.

Detailed definition

The reduction in the liability for unrecognized tax benefits due to the expiration of the statute of limitations in vari...

Peer comparison

Commonly reported by multinational corporations as a component of tax reserve reconciliations.

Metric ID: is_isrg_unrecognized_tax_benefits_statute_lapse

Historical Data

3 years
 FY'23FY'24FY'25
Value$8.10M$16.60M$10.70M
YoY Change—+104.9%-35.5%
Range$8.10M – $16.60M
CAGR+14.9%
Avg YoY Growth+34.7%
Median YoY Growth+34.7%

Frequently Asked Questions

What is Vertex Pharmaceuticals's unrecognized tax benefits reevaluation (statute lapse)?
Vertex Pharmaceuticals (VRTX) reported unrecognized tax benefits reevaluation (statute lapse) of $2.68M in Q4 2025.
How has Vertex Pharmaceuticals's unrecognized tax benefits reevaluation (statute lapse) changed year-over-year?
Vertex Pharmaceuticals's unrecognized tax benefits reevaluation (statute lapse) decreased by 35.5% year-over-year, from $4.15M to $2.68M.
What is the long-term trend for Vertex Pharmaceuticals's unrecognized tax benefits reevaluation (statute lapse)?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's unrecognized tax benefits reevaluation (statute lapse) has grown at a 14.9% compound annual growth rate (CAGR), from $8.10M to $10.70M.
What does unrecognized tax benefits reevaluation (statute lapse) mean?
The decrease in tax reserves because the time limit for tax authorities to audit those specific tax positions has expired.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.